Back
Nuveen Core Plus Impact Fund Vs. Repligen Industry Stock Comparison
Buy
59
NPCT
Nuveen Core Plus Impact Fund
Last Price:
11.09
Seasonality Move:
2.13%
Sell
30
RGEN
Repligen
Last Price:
122.65
Seasonality Move:
7.3%
Buy
59
Nuveen Core Plus Impact Fund (NPCT)
is a Buy
Is Nuveen Core Plus Impact Fund a Buy, Sell or Hold?
- The current Nuveen Core Plus Impact Fund [NPCT] share price is $11.04. The Score for NPCT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- NPCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NPCT Stock Price Chart
What is Nuveen Core Plus Impact Fund's stock price today?
-
The Nuveen Core Plus Impact Fund share price today is $11.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCT is experiencing selling pressure, which indicates risk of future bearish movement.
NPCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 32.83 | Sell |
| Chaikin Money Flow: | -73643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.19 - 11.47) | Sell |
| Bollinger Bands (100): | (11.19 - 11.67) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 36.22 | Sell |
| Chaikin Money Flow: | -1285419 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.94 - 146.38) | Sell |
| Bollinger Bands (100): | (130 - 153.64) | Sell |
NPCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.3 | Sell |
| 20-day SMA: | 11.28 | Sell |
| 50-day SMA: | 11.52 | Sell |
| 200-day SMA: | 10.92 | Buy |
| 8-day EMA: | 11.24 | Sell |
| 20-day EMA: | 11.32 | Sell |
| 50-day EMA: | 11.4 | Sell |
| 200-day EMA: | 11.02 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.02 | Sell |
| 20-day SMA: | 140.23 | Sell |
| 50-day SMA: | 141.19 | Sell |
| 200-day SMA: | 157.58 | Sell |
| 8-day EMA: | 139.7 | Sell |
| 20-day EMA: | 140.54 | Sell |
| 50-day EMA: | 141.71 | Sell |
| 200-day EMA: | 151.3 | Sell |
Nuveen Core Plus Impact Fund Earnings Growth & NPCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
Nuveen Core Plus Impact Fund Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||